RNASEL
protein-codingribonuclease L, the group of Endoribonucleases|Ankyrin repeat domain containing
Gene summary
This gene encodes a component of the interferon-regulated 2-5A system that functions in the antiviral and antiproliferative roles of interferons. The protein is involved in innate immunity and is active against multiple RNA viruses, including the influenza and SARS-CoV-2 viruses. Mutations in this gene have been associated with predisposition to prostate cancer and this gene is a candidate for the hereditary prostate cancer 1 (HPC1) allele. [provided by RefSeq, Nov 2021]
- RNS4
- PRCA1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~15.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0035375
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0011098
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0011098
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Oncologic
Intervention: Oncologic
Rationale: Surveillance and early diagnosis could potentially be beneficial
Comments: Variants may be involved in susceptibility to multiple cancer types
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RNASEL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021133.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 9 | 3 | 20 | ||
| missense | 2 | 85 | 10 | 3 | 100 | |
| nonsense | 1 | 2 | 1 | 4 | ||
| start loss | 1 | 1 | ||||
| frameshift | 41 | 41 | ||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 1 | 3 | 139 | 20 | 6 | 169 |
Highest pathogenic variant AF is 0.000023543611
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_066956.1 | 6 | MANE Select | |
| Ensembl | ENSP00000356530.3 | 6 | MANE Select | |
| Ensembl | ENSP00000440844.1 | 5 | Standard | |
| Ensembl | ENSP00000440844.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Influenza A - Homo sapiens (human)
- NOD-like receptor signaling pathway - Homo sapiens (human)
- Hepatitis C - Homo sapiens (human)
- Herpes simplex infection - Homo sapiens (human)
- Senescence and Autophagy in Cancer
Biological Process
- rRNA processing
- mRNA processing
- protein phosphorylation
- regulation of mRNA stability
- negative regulation of viral genome replication
Molecular Function
- RNA binding
- endoribonuclease activity
- protein kinase activity
- protein binding
- ATP binding
Cellular Component
- cellular_component
- mitochondrial matrix
- cytosol
- nuclear matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367559
- Coding exons
- 6
- Length
- 15623
- Individuals with no LoFs
- 124628
- Homozygous LoFs
- 3
- Heterozygous LoFs
- 1114
- Defined
- 125745
- p
- 0.00445
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.159 | 386 | 395 | 0.977 | 0.0000216 | 4915 |
| Missense (PolyPhen) | 128 | 127.92 | 1.0006 | 1606 | ||
| Synonymous | 0.550 | 148 | 157 | 0.944 | 0.00000890 | 1433 |
| Loss of Function | 1.06 | 18 | 23.6 | 0.764 | 0.00000137 | 296 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00062 | 0.00062 | rare |
| Latino/Admixed American | 0.0021 | 0.0020 | notable |
| Ashkenazi Jewish | 0.015 | 0.015 | notable |
| East Asian | 0.00071 | 0.00071 | rare |
| Finnish | 0.0083 | 0.0083 | notable |
| European (Non-Finnish) | 0.0055 | 0.0054 | notable |
| South Asian | 0.0019 | 0.0019 | notable |
| Other | 0.0039 | 0.0039 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Endoribonuclease that functions in the interferon (IFN) antiviral response. In INF treated and virus infected cells, RNASEL probably mediates its antiviral effects through a combination of direct cleavage of single-stranded viral RNAs, inhibition of protein synthesis through the degradation of rRNA, induction of apoptosis, and induction of other antiviral genes. RNASEL mediated apoptosis is the result of a JNK-dependent stress- response pathway leading to cytochrome c release from mitochondria and caspase-dependent apoptosis. Therefore, activation of RNASEL could lead to elimination of virus infected cells under some circumstances. In the crosstalk between autophagy and apoptosis proposed to induce autophagy as an early stress response to small double-stranded RNA and at later stages of prolonged stress to activate caspase-dependent proteolytic cleavage of BECN1 to terminate autophagy and promote apoptosis (PubMed:26263979). Might play a central role in the regulation of mRNA turnover (PubMed:11585831). Cleaves 3' of UpNp dimers, with preference for UU and UA sequences, to sets of discrete products ranging from between 4 and 22 nucleotides in length. {ECO:0000269|PubMed:11585831, ECO:0000269|PubMed:26263979}.;
- Disease
- DISEASE: Prostate cancer, hereditary, 1 (HPC1) [MIM:601518]: A condition associated with familial predisposition to cancer of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. {ECO:0000305|PubMed:11799394, ECO:0000305|PubMed:11941539, ECO:0000305|PubMed:12415269, ECO:0000305|PubMed:17344846}.;
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- LoFtool
- 0.685
- RVIS EVS
- -0.17
- RVIS percentile EVS
- 40.63
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.255
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |